Merck Comprehensive Income 2010-2024 | MRK

Merck comprehensive income for the quarter ending September 30, 2024 was $-5.371B, a 9.26% increase year-over-year.

  • Merck comprehensive income for 2023 was $-5.161B, a 8.24% increase from 2022.
  • Merck comprehensive income for 2022 was $-4.768B, a 7.65% increase from 2021.
  • Merck comprehensive income for 2021 was $-4.429B, a 33.24% decline from 2020.

Merck Comprehensive Income 2010-2024 | MRK

  • Merck comprehensive income for 2023 was $-5.161B, a 8.24% increase from 2022.
  • Merck comprehensive income for 2022 was $-4.768B, a 7.65% increase from 2021.
  • Merck comprehensive income for 2021 was $-4.429B, a 33.24% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B